Summary
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Brazilian pharmaceuticals market had total revenues of $23.6bn in 2020, representing a compound annual growth rate (CAGR) of 5% between 2016 and 2020.
- A strong economic outlook in Brazil as the country recovers from the impact of the COVID-19 pandemic could attract pharmaceutical companies to expand their production and manufacturing capacities in Brazil, helping to maintain growth in the market.
- An aging population in Brazil is likely to sustain demand for pharmaceutical products, as a growing population of elderly citizens is increasing the incidence of chronic and lifestyle diseases.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Brazil pharmaceuticals market by value in 2020?
- What will be the size of the Brazil pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Brazil pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Brazil's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any other notable players in the market?
8 Company Profiles
8.1. Sanofi SA
8.2. Ache Laboratorios Farmaceuticos SA
8.3. Hypera SA
8.4. EMS Sigma Pharma
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Brazil pharmaceuticals market value: $ billion, 2016-20
Table 2: Brazil pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Brazil pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Brazil pharmaceuticals market share: % share, by value, 2020
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: Ache Laboratorios Farmaceuticos SA: key facts
Table 10: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 11: Hypera SA: key facts
Table 12: Hypera SA: Annual Financial Ratios
Table 13: Hypera SA: Key Employees
Table 14: EMS Sigma Pharma: key facts
Table 15: EMS Sigma Pharma: Key Employees
Table 16: Brazil size of population (million), 2016-20
Table 17: Brazil gdp (constant 2005 prices, $ billion), 2016-20
Table 18: Brazil gdp (current prices, $ billion), 2016-20
Table 19: Brazil inflation, 2016-20
Table 20: Brazil consumer price index (absolute), 2016-20
Table 21: Brazil exchange rate, 2016-20
List of Figures
Figure 1: Brazil pharmaceuticals market value: $ billion, 2016-20
Figure 2: Brazil pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Brazil pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Brazil, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Brazil, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Brazil, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2020
Figure 10: Brazil pharmaceuticals market share: % share, by value, 2020
